Mel Sorensen serves as Executive at Galera Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Mel Sorensen has executed 5 insider transactions totaling $174.1K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 20, 2025 involved selling 70,000 shares valued at $1.4K.
Mel Sorensen currently holds 195,029 shares of Galera Therapeutics, Inc. (GRTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mel Sorensen has been a net buyer of GRTX stock. They have purchased $168.0K and sold $6.1K worth of shares.
Mel Sorensen's most recent insider trade was on Nov 20, 2025, when they sold 70,000 shares at $0.02 per share.
Get notified when new Form 4 filings are submitted
| $0.07 |
| Discretionary |
| Mar 10, 2023 | GRTX | $168.0K | Purchase | 100,000 | $1.68 | Discretionary |
| Mar 26, 2021 | GRTX | $53.5K | Option Exercise | 46,940 | $1.14 | Discretionary |
| Mar 26, 2021 | GRTX | $182.0K | Option Exercise | 170,075 | $1.07 | Discretionary |